Nerissa Kreher has sold TRDA and made no open-market buys since Sep 2022

Insider Type: Person

Nerissa C. Kreher, MD, MBA, is a physician executive and pediatric endocrinologist with extensive experience in biotechnology, specializing in the development of therapies for patients with rare diseases across multiple therapeutic areas.( She has held senior leadership roles in both private and public biotech companies, including serving as Chief Medical Officer (CMO) at Entrada Therapeutics, Inc. (TRDA), where she led clinical and regulatory strategy, medical affairs, and patient advocacy efforts for the company’s rare disease pipeline.( In this capacity, she was a corporate insider at Entrada Therapeutics, participating in the company’s growth and public-market activities.(

Over her career, Kreher has served as CMO at Tiburio Therapeutics and AVROBIO, overseeing clinical development for multiple gene therapy and rare disease programs, and previously held leadership roles as Global Head (VP) of Clinical and Medical Affairs at Zafgen, as well as key positions at Shire and Enobia Pharma, where she contributed to Alexion’s multibillion-dollar acquisition of Enobia.( She currently serves as Chief Medical Officer at Alltrna and as an independent board member of Rezolute Bio, while also founding Mountainview Clinical Development Consulting, LLC.( Kreher holds an M.D. from East Carolina University School of Medicine, an M.S. in Clinical Research from Indiana University, and an Executive MBA from Northeastern University, and is board certified in Pediatric Endocrinology by the American Board of Pediatrics.(

Written by Perplexity from public sources.